Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Argan (AGX) Change in Accured Expenses: 2009-2025

Historic Change in Accured Expenses for Argan (AGX) over the last 17 years, with Oct 2025 value amounting to $11.9 million.

  • Argan's Change in Accured Expenses rose 272.79% to $11.9 million in Q4 2025 from the same period last year, while for Oct 2025 it was $22.4 million, marking a year-over-year decrease of 53.94%. This contributed to the annual value of $66.2 million for FY2025, which is 346.57% up from last year.
  • As of Q4 2025, Argan's Change in Accured Expenses stood at $11.9 million, which was down 56.97% from $27.6 million recorded in Q3 2025.
  • Over the past 5 years, Argan's Change in Accured Expenses peaked at $33.0 million during Q3 2024, and registered a low of -$39.6 million during Q2 2025.
  • For the 3-year period, Argan's Change in Accured Expenses averaged around $8.2 million, with its median value being $14.5 million (2023).
  • In the last 5 years, Argan's Change in Accured Expenses skyrocketed by 2,112.18% in 2023 and then crashed by 629.79% in 2025.
  • Argan's Change in Accured Expenses (Quarterly) stood at -$11.2 million in 2021, then skyrocketed by 173.14% to $8.2 million in 2022, then soared by 131.17% to $18.9 million in 2023, then slumped by 83.13% to $3.2 million in 2024, then skyrocketed by 272.79% to $11.9 million in 2025.
  • Its last three reported values are $11.9 million in Q4 2025, $27.6 million for Q3 2025, and -$39.6 million during Q2 2025.